Capital Fund Management (CFM)
SUPN icon

Capital Fund Management (CFM)’s Supernus Pharmaceuticals SUPN Stock Holding History

Capital Fund Management (CFM)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Buy
73,219
+43,504
+146% +$2.09M 0.02% 1128
2026
Q1 		$1.54M Buy
+29,715
New +$1.51M 0.01% 1494
2025
Q4 		– Sell
-23,328
Closed -$1.11M – 2646
2025
Q3 		$1.11M Buy
+23,328
New +$939K ﹤0.01% 2057
2019
Q2 		– Sell
-227,078
Closed -$7.96M – 1900
2019
Q1 		$7.96M Sell
227,078
-75,577
-25% -$2.81M 0.07% 361
2018
Q4 		$10.1M Buy
302,655
+68,478
+29% +$2.94M 0.09% 315
2018
Q3 		$11.8M Sell
234,177
-21,285
-8% -$1.05M 0.06% 428
2018
Q2 		$15.3M Buy
255,462
+131,060
+105% +$6.79M 0.08% 341
2018
Q1 		$5.7M Buy
124,402
+33,536
+37% +$1.4M 0.03% 641
2017
Q4 		$3.62M Buy
+90,866
New +$3.59M 0.02% 782
2016
Q1 		– Sell
-35,800
Closed -$481K – 1816
2015
Q4 		$481K Buy
+35,800
New +$554K ﹤0.01% 1136
2015
Q1 		– Sell
-31,100
Closed -$258K – 1705
2014
Q4 		$258K Buy
+31,100
New +$261K ﹤0.01% 1404

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Capital Fund Management (CFM)'s SUPN Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its Supernus Pharmaceuticals (SUPN) stake by 146% in Q2 2026, buying an estimated $2.09M and bringing the position to 73,219 shares worth $3.41M. The position accounts for 0.02% of the portfolio, ranked #1128.

Capital Fund Management (CFM) first reported a position in SUPN in Q4 2014 and has held it in 11 quarters since. The position peaked at $15.3M in Q2 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Capital Fund Management (CFM) held 73,219 shares of Supernus Pharmaceuticals worth $3.41M as of Q2 2026.
  • Capital Fund Management (CFM) bought 43,504 Supernus Pharmaceuticals shares in Q2 2026, an estimated $2.09M.
  • Supernus Pharmaceuticals made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1128 holding.
  • Capital Fund Management (CFM) first reported a position in Supernus Pharmaceuticals in Q4 2014 and has held it in 11 quarters since.
  • Capital Fund Management (CFM)'s Supernus Pharmaceuticals position peaked at $15.3M in Q2 2018.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.